In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine Following the previous articles where we discussed the treatment of cancer, pain, psoriasis and rheumatoid arthritis, this fourth piece focuses on the use of cannabinoids to treat epilepsy. Cannabinoids and epilepsy […]
Cannabidiol (CBD) Market Market Study Report Has Added A New Report On Cannabidiol (CBD) Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market Size. Comprising The Current And Future Trends Defining The Dynamics Of This Industry Vertical, This Report Also Incorporates […]
When It comes to the topic of cannabidiol (CBD) there is no debating the fact it is everywhere and in everything from coffee to gummies to hand lotions and even in pet food. And the products containing it seem to claim it does everything, like a modern day “cure-all.” FDA […]
Advertisement Charlotte Figi was three months old when she had her first epileptic seizure. The episode appeared to come out of nowhere, as Charlotte’s early infancy, as well as her fraternal twin’s first few months, had been smooth sailing up until that point. As her parents, Matt and Paige, stood […]
TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that the Uruguayan Ministry of Public Health, (Ministerio de Salúd Publica or “MSP”) has approved and registered XALEX™ […]
Overview Cannabidiol (CBD) has become increasingly popular due to its high potency and medical efficacy. According to a University of Alabama, a CBD oil epilepsy study overseen by the Food and Drug Administration conducted a clinical trial with patients. ADVERTISEMENT They concluded that patients who used CBD oil for seizures […]
The shortage of Chinese ingredients, raw materials, and semi-finished goods is the latest example of the global economy’s dependence on products made in China, from iPhones to auto parts to pharma. Much of the fallout may still be hidden and is likely to play out over months. Even before the […]
Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called […]
In patients with epilepsy, normal neurological activity becomes disrupted, causing debilitating seizures. Now, researchers report in ACS Chemical Neuroscience that they have found a potential new treatment for this disorder by turning to traditional Chinese medicine. Tests of extracts from plants used in these ancient remedies led the team to […]
19 Mar Cannabidiol: Conflicts of Interest Among Authors of Published CBD Articles MedicalResearch.com Interview with: Dr. Wallach Joshua D. Wallach, MS, PhDAssistant Professor of Epidemiology (Environmental Health Sciences)Yale School of Public HealthNew Haven, CT MedicalResearch.com: What is the background for this study? Response: Over the past few years, there has […]
